High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes.
Sven–Erik Bursell(Joslin Diabetes Center), George L. King(Joslin Diabetes Center), Lloyd Paul Aiello(Joslin Diabetes Center), L M Aiello(Joslin Diabetes Center), Lori M. Laffel(Joslin Diabetes Center), D. Schlossman(Joslin Diabetes Center), Allen C. Clermont(Joslin Diabetes Center), Edward P. Feener(KalVista Pharmaceuticals (United States))
Cited by 332
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
|Diabetes Care|2019|3.8k
International Consensus on Use of Continuous Glucose Monitoring
|Diabetes Care|2017|2k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k